ABSTRACT: Batrachochytrium dendrobatidis (Bd) is a global threat to amphibian biodiversity. Current calls for conservation through captive breeding require that efficient and reliable antifungal treatments be developed for target species. Here we confirm that the antifungal itraconazole is an effective treatment for infection in larval Alytes muletensis. Exceptionally low doses applied as few as 7 times were effective at clearing infection from tadpoles for up to 28 d after treatment. However, we cannot recommend itraconazole as a treatment for this species as depigmentation of tadpoles was observed. Further research is required to determine the putative hepatotoxicity of this treatment.
INTRODUCTION
Batrachochytrium dendrobatidis (Bd) is recognized internationally as a major and global threat to amphibian populations and species; this has resulted in calls for immediate conservation actions that mitigate the impact of disease (Mendelson et al. 2006) . Captive populations and breeding are widely cited as necessary steps towards ensuring species conservation, as extinction in the wild due to chytridiomycosis is a strong possibility (La Marca et al. 2005 , Schloegel et al. 2006 , Skerratt et al. 2007 ). However, it is becoming increasingly clear that some captive amphibian populations are rife with infection, and suffer catastrophic losses due to chytridiomycosis (Berger et al. 1998 , Parker et al. 2002 , Fisher & Garner 2007 . It is essential to develop treatment protocols that will allow the Amphibian Ark (www.amphibianark.org/) and other programmes to bring highly threatened species into captivity to cure animals of infection and to maintain (Bd)-free populations.
Current published treatments include elevated temperature (Woodhams et al. 2003) , formalin/malachite green (Parker et al. 2002) , salt (White 2006 ) and standard veterinary antifungals (Marantelli et al. 2000 , Nichols & Lamirande 2000 , Hadfield & Whitaker 2005 . Elevating temperature, altering salinity and exposing animals to toxic compounds to treat infection, while effective in some amphibians, are hampered by the physiological constraints of the majority of species, as most amphibians do not respond well to elevated temperature or salinity. Practical constraints associated with regional and international legislation are another consideration. Malachite green intercalates with double-stranded DNA, is a proven mutagen, is presumed to be carcinogenic and is cytotoxic in mammalian cells (Culp & Beland 1996) . For these and other reasons, malachite green is not approved as an aquatic veterinary drug in North America and Europe (Andersen et al. 2004 ). In comparison, antifungal drugs may be well tolerated by a wide range of amphibian species, especially when used at low concentrations (Pessier 2008 ).
However, larvae are highly sensitive to chemicals (Bridges & Semlitsch 2000 , Relyea 2003 , and it is not known whether they can survive exposure to typical veterinary drugs at the concentrations required to clear Bd infections. Certainly there is a growing interest in treating the larval stages of amphibians, as much mortality reported in field studies occurs at or soon after metamorphosis (Bosch & Martínez-Solano 2006) .
In this paper we describe an experimental investigation of the utility of itraconazole as an antifungal treatment against Bd infection in the Mallorcan midwife toad Alytes muletensis. Recent and successful conservation efforts mitigating the effects of invasive predators, competitors and habitat degradation have resulted in the species being downgraded from endangered to vulnerable (IUCN Red List, vulnerable D2), but now chytridiomycosis has emerged in wild populations (Walker et al. 2008) . Current estimates place the total number of breeding adults at about 3000 (S. Pinya pers. comm.) and the number of (sub)populations at 30. Existing captive breeding populations have also suffered from chytridiomycosis (Walker et al. 2008) , and it is clear that species-specific treatments are urgently required.
MATERIALS AND METHODS
We selected itraconazole (Itrafungol, Janssen Animal Health) as a possible treatment based on previously published reports (Nichols & Lamirande 2001) and experience in the veterinary department of the Zoological Society of London (ZSL). The solution of itraconazole used contained only sugars and alcohol solvents (propylene glycol), so all effects measured in the present study should be attributable to the antifungal itself. We used tadpoles produced by the Durrell Wildlife Conservation Trust (DWCT) captive breeding programme, which we have been surveying for infection for several years. A subset of these tadpoles were tested to ensure that study animals were not infected with Bd beforehand. We kept all other experimental animals individually in 1 l plastic boxes containing 750 ml tap water aged 3 d. Tadpoles were fed 900 mg ground Tetra TabiMin (Tetra GmbH) every 3 d, with water changed every 4th day. We exposed tadpoles individually and over the course of 2 wk to 4 doses of a minimum of 5000 active Bd zoospores in liquid mTGhL media (minimum 8 g tryptone, 2 g gelatin hydrolysate, 4 g lactose in 1 l total volume distilled water).
From previous experience, we had determined what volume of media to box water would not result in bacterial blooms (300 µl in 140 ml): all doses administered were well below this. We used an isolate recovered from a dead common midwife toad Alytes obstetricans collected at a mass mortality event in the Pyrenees (M. C. Fisher unpubl. data).
At 2 wk post-infection, 5 individuals were euthanized to assess the efficacy of the infection protocol. The remaining tadpoles were randomly assigned to one of 12 treatments. These included 3 groups of positive controls (infected), each composed of 4 to 5 tadpoles. Positive control groups were euthanized 14, 21 or 28 d post-treatment and were used to prove the maintenance of infection during the course of the experiment. The other 9 treatments were composed of 6 tadpoles per group and defined by the strength of the itraconazole baths (0.5, 1.0 and 1.5 mg l -1 , subsequently referred to as low, medium and high) and the number of days tadpoles were given 5 min baths at their respective concentrations (7, 14 or 21 d of baths). Tadpoles treated with itraconazole were kept an additional week after the final bath exposure before euthanasia. We did this to allow any subclinical Bd infections to regenerate after exposure to itraconazole was completed. Euthanasia in all cases was performed using an overdose of buffered MS-222 (5% tricaine methane sulphonate buffered to pH 7 with standard baking soda). All procedures were done under licence from the Home Office (70/6227) following full ethical review.
Euthanized tadpoles were stored in 70% ethanol until the end of the experiment. Upon completion of the experiment, the mouthparts of each tadpole were excised, resuspended in 50 µl of PrepMan Ultra (Applied Biosystems) and extracted following the bead-beating protocol of Boyle et al. (2004) . Extractions were diluted 1/10 and amplified using the real time quantitative polymerase chain reaction (qPCR) procedure of Boyle et al. (2004) . All qPCRs were performed in duplicate with negative controls and 4 dilutions of concentration standards (100, 10, 1 and 0.1 zoospore genomic equivalents, or GE).
RESULTS
Tadpoles sourced from DWCT were considered uninfected upon delivery; this population has been screened for several years, and Bd was not detected by qPCR from the mouthparts of the 5 reference specimens (T. W. J. Garner unpubl. data). One positive control tadpole died of unknown causes 2 d after the first dose of Bd. This individual also tested negative for infection. Results of qPCR assays of positive control specimens taken through the entire infection protocol showed infection was stably maintained throughout the course of the experiment. Prevalence of B. dendrobatidis in positive control groups ranged from 75 to 100%. One of 5 tadpoles euthanized immediately after the cessation of infections exhibited no sign of infection, while all others tested positive (mean GE ± SE = 15.7 + 12.8). Individuals sampled on Day 14 averaged similar levels of infection with 1 of 4 testing negative (16.6 ± 14.9). The infection burden increased by Day 21 (all 4 tadpoles infected, 29.05 ± 11.5) and by Day 28 all 4 individuals were infected (41.3 ± 29.5); however, this increase was not statistically significant (linear regression, p = 0.27).
In contrast, all tadpoles infected with Bd and then treated with itraconazole showed a comprehensive lack of detectable infection. All extractions from individuals, treated with the antifungal tested negative for the presence of Bd, including the 2 tadpoles that died 5 d before they were due for euthanasia (low dose, 7 d bath protocol). Tadpoles did not exhibit any stressful behaviour when immersed in the itraconazole solution (i.e. 'panic' swimming), and often attempted to forage on the floor of the bath container. Tadpoles did exhibit significant depigmentation in all itraconazole treatments ( Fig. 1) and some depigmentation in the Bd-positive controls; however, we did not record which individuals appeared depigmented in which treatments, and cannot state irrefutably that specific treatment(s) did not result in depigmentation. As these observations were unpredicted, opportunistic and anecdotal, we were unable to perform any statistical comparisons among treatments.
DISCUSSION
Itraconazole appears to be a reliable antifungal for the elimination of Bd infection from Alytes muletensis tadpoles given our experimental design. No sign of Bd could be ascertained from any of our antifungal treatment specimens. This is unlikely to be due to any host immunological response, as our positive control individuals exhibited infection throughout the course of the experiment and infection burdens increased in the latter stages of the experiment. Other researchers have also had success with itraconazole as a treatment. Nichols & Lamirande (2000) used a 0.01% solution in 0.6% saline over 11 d of 5 min treatments to successfully eliminate infection in juvenile blue-and-yellow poison dart frogs. Only 8 d of itraconazole baths resolved infection in subadult and adult individuals of the same species (Nichols & Lamirande 2000) . The only report describing the treatment of tadpoles is by Banks & McCracken (2002) , who report the inefficacy of Plistopur ® (Sera) followed by griseofulvin against chytridiomycosis in sharp-snouted dayfrog tadpoles. To the best of our knowledge the present study is the first report of the use of itraconazole treatment for curing Bd infection in premetamorphic amphibians.
Itraconazole does not appear to be an irritant to Alytes muletensis tadpoles, as tadpoles did not appear agitated and exhibited foraging behaviour when exposed to all concentrations of the antifungal. Furthermore, tadpoles fed well after treatment, and no mortality, morbidity or lethargy was observed in any of the experimental tadpoles. Nevertheless, we cannot recommend itraconazole as a treatment for chytridiomycosis in larval A. muletensis without further testing, which is currently underway. The depigmentation we observed in our experimental tadpoles suggests that the production of melanin may in some way have been impaired by itraconazole treatment. Melanin is produced in many cells including the Kupffer cells in amphibian livers (Sichel et al. 2002) . Additionally, hepatotoxic side effects of itraconazole have been reported in mammals (Collazos et al. 1995 , Somchit et al. 2004 ; therefore, before itraconazole is adopted as a general treatment for larval amphibians, we suggest more research be undertaken to identify any potential side effects of this antifungal agent. 
